Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
29 hedge funds and large institutions have $42.5M invested in Global Cord Blood Corporation in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.
205% more call options, than puts
Call options by funds: $507K | Put options by funds: $166K
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
4% more funds holding
Funds holding: 28 → 29 (+1)
6% less capital invested
Capital invested by funds: $45.1M → $42.5M (-$2.58M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$2.59M |
| 2 |
Man Group
London,
United Kingdom
|
+$379K |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$267K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$106K |
| 5 |
Morgan Stanley
New York
|
+$69.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$823K |
| 2 |
TSC
Two Seas Capital
Rye,
New York
|
-$519K |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$428K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$352K |
| 5 |
Rockefeller Capital Management
New York
|
-$331K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $2K | +$1.71K | +412 | New |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $2K | +$1.9K | +457 | New |
|
|
OA
28
Operose Advisors
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
|
TSC
29
Two Seas Capital
Rye,
New York
| – | -$519K | -123,800 | Closed |
|
|
30
Verition Fund Management
Greenwich,
Connecticut
| – | -$352K | -84,017 | Closed |
|
|
31
Rockefeller Capital Management
New York
| – | -$331K | -79,080 | Closed |
|
|
HF
32
HRT Financial
New York
| – | -$58K | -14,051 | Closed |
|
|
ICM
33
ISZO Capital Management
New York
| – | -$4K | -1,000 | Closed |
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -416 | Closed |
|
CO Hedge Fund Activity: Q1 2022 in Review
29 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2022, worth a combined $42.5M — down 5.7% from $45.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CO positions and 6 closed out — a net gain of 1 holder — while 9 added to existing stakes and 4 trimmed.
The largest buyer was Oasis Management Company, adding an estimated $2.59M. The largest seller was Renaissance Technologies, cutting an estimated $823K.
- 29 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2022, up from 28 in Q4 2021.
- Funds reported $42.5M of Global Cord Blood Corporation stock for Q1 2022, down 5.7% quarter-over-quarter.
- 7 funds opened new Global Cord Blood Corporation positions in Q1 2022 and 6 closed out, a net change of +1 holder.
- The largest Global Cord Blood Corporation buyer in Q1 2022 was Oasis Management Company, an estimated $2.59M added.
- The largest Global Cord Blood Corporation seller in Q1 2022 was Renaissance Technologies, an estimated $823K sold.
Based on aggregated 13F filings for Q1 2022.